title: [Thrombin and anticoagulant therapy].
abstract: New data which reveal rational approaches for pharmacologic control of blood coagulation process and confirm the key role of thrombin in haemostasis processes compared with other proteinases are presented in the review. Modulation of thrombin properties described in the review gives a new possibility for creating anti-thrombin preparations. Thrombin allosteria can serve a basis for development of new therapy. Creation of catalytically inert thrombin in slow-form within efficient anti-coagulant activity in vivo will allow using it in medicine as a unique anti-thrombin agent.
authors.forename: M V
authors.initials: MV
authors.lastname: Kolodzeĭskaia
authors.forename: L I
authors.initials: LI
authors.lastname: Sokolovskaia
authors.forename: V A
authors.initials: VA
authors.lastname: Chernyshenko
authors.forename: E V
authors.initials: EV
authors.lastname: Lugovskoĭ
mesh_terms: D000494:Allosteric Regulation; D000818:Animals; D000925:Anticoagulants / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000502:physiology*; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000201:enzymology; D013329:Structure-Activity Relationship; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000502:physiology*
chemical_list: D000925:Anticoagulants; D013917:Thrombin